Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization
Abstract
A new process for the enantiomeric separation of racemic 3,6-dihydro-1,3,5-triazine derivatives for the treatment of disorders associated with insulin-resistance syndrome, by preferential crystallization.